Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| 1 |
NVIDIA
NVDA
|
$1.49B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$1.27B |
| 3 |
Microsoft
MSFT
|
$1.26B |
| 4 |
Intercontinental Exchange
ICE
|
$824M |
| 5 |
Parker-Hannifin
PH
|
$724M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$1.81B |
| 2 |
Visa
V
|
$936M |
| 3 |
Fortive
FTV
|
$727M |
| 4 |
Invesco QQQ Trust
QQQ
|
$462M |
| 5 |
TSMC
TSM
|
$400M |
Sector Composition
| 1 | Financials | 19.73% |
| 2 | Technology | 19.28% |
| 3 | Industrials | 7.79% |
| 4 | Consumer Discretionary | 7.58% |
| 5 | Healthcare | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
First Trust Value Line Dividend Fund
FVD
$9.15B
| $169M | 0.03% |
3,882,042
-116,490
| -3% | -$5.08M |
|
377
Edwards Lifesciences
EW
$47.5B
| $169M | 0.03% |
2,287,681
+315,968
| +16% | +$23.4M |
|
378
Prudential Financial
PRU
$37.2B
| $168M | 0.03% |
1,420,697
+357,230
| +34% | +$42.3M |
|
379
iShares Russell 1000 ETF
IWB
$43.4B
| $166M | 0.03% |
515,676
-68,008
| -12% | -$21.9M |
|
380
Unilever
UL
$158B
| $166M | 0.03% |
2,926,892
+14,083
| +0.5% | +$799K |
|
381
Microchip Technology
MCHP
$35.6B
| $166M | 0.03% |
2,888,806
-857,759
| -23% | -$49.2M |
|
382
SPDR Portfolio S&P 500 Growth ETF
SPYG
$40.8B
| $164M | 0.03% |
1,861,628
+68,942
| +4% | +$6.06M |
|
383
NetApp
NTAP
$23.7B
| $164M | 0.03% |
1,408,716
-26,282
| -2% | -$3.05M |
|
384
Alibaba
BABA
$323B
| $163M | 0.03% |
1,926,904
-221,248
| -10% | -$18.8M |
|
385
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.89B
| $163M | 0.03% |
4,518,829
+276,173
| +7% | +$9.96M |
|
386
WisdomTree Floating Rate Treasury Fund
USFR
$18.9B
| $162M | 0.03% |
3,218,770
+164,141
| +5% | +$8.26M |
|
387
iShares Ultra Short Duration Bond Active ETF
ICSH
$6.18B
| $162M | 0.03% |
3,211,056
-908,694
| -22% | -$45.8M |
|
388
ATS Corp
ATS
$2.67B
| $162M | 0.03% |
5,307,964
+1,452,667
| +38% | +$44.3M |
|
389
iShares MBS ETF
MBB
$41.3B
| $161M | 0.03% |
1,759,512
-59,356
| -3% | -$5.44M |
|
390
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.8B
| $161M | 0.03% |
1,508,436
+417,386
| +38% | +$44.6M |
|
391
iShares Biotechnology ETF
IBB
$5.8B
| $159M | 0.03% |
1,206,172
-266,253
| -18% | -$35.2M |
|
392
AstraZeneca
AZN
$253B
| $159M | 0.03% |
2,432,811
-58,380
| -2% | -$3.83M |
|
393
iShares Gold Trust
IAU
$52.6B
| $159M | 0.03% |
3,214,391
-373,729
| -10% | -$18.5M |
|
394
TotalEnergies
TTE
$133B
| $159M | 0.03% |
2,917,438
+265,251
| +10% | +$14.5M |
|
395
Ryanair
RYAAY
$32.1B
| $159M | 0.03% |
3,642,795
+179,006
| +5% | +$7.8M |
|
396
Dr. Reddy's Laboratories
RDY
$11.9B
| $158M | 0.03% |
10,037,246
+61,831
| +0.6% | +$976K |
|
397
FirstEnergy
FE
$25.1B
| $158M | 0.03% |
3,981,944
+206,000
| +5% | +$8.19M |
|
398
Vanguard Extended Market ETF
VXF
$24.1B
| $157M | 0.03% |
823,874
+48,028
| +6% | +$9.12M |
|
399
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$16.3B
| $156M | 0.03% |
3,035,290
+206,157
| +7% | +$10.6M |
|
400
Northern Trust
NTRS
$24.3B
| $153M | 0.03% |
1,497,484
+562,976
| +60% | +$57.7M |
|